Ares Management (ARES)
NYSEFinancialsAsset ManagementSnapshot 2026-09-04
NYSEFinancialsAsset ManagementSnapshot 2026-09-04
QuarterlyIQ Insights · ARES
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $140 ARES trades at 27× p/e — 1.7× the 16× p/e peer median. The market is re-rating it beyond its own range; our $136 fair value is medium-confidence here. Analysts target $128–$168. Even valued only for durable growth at sustainable margins, it's worth about $174 — above today's price, so the premium reflects that growth case, not pure multiple expansion. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $144.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $317.20 | — | — | Analyst | high |
| dcf fcff | 12M | $340.16 | — | — | Analyst | high |
| ddm gordon | 12M | $62.41 | — | — | TTM | high |
| graham number | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$128.00 – $168.00 (median $144.00) · 7 analysts · as of 2026-08-03
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Self-history needs ~20 months of data.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $111.37 |
| — |
| — |
| TTM |
| high |
| Peer P/B | 12M | $205.95 | 1.9 | 106.63 | TTM | high |
| Peer P/FCF | 12M | $140.15 | 13.5 | 10.36 | TTM | high |
| Peer P/E | 12M | $90.05 | 13.2 | 6.83 | ntm analyst | high |
| Peer P/S | 12M | $213.39 | 3.2 | 65.73 | TTM | high |
| PEG | 12M | $135.23 | 26.2 | 5.17 | TTM | high |
| residual income | 12M | $84.35 | — | — | TTM | high |
| triangulated | 12M | $83.84 | 16.3 | 5.13 | Triangulated | high |
| Peer P/B | 3Y | $313.22 | 1.9 | 162.17 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $125.85 | 13.2 | 9.54 | Analyst | medium |
| Peer P/S | 3Y | $324.91 | 3.2 | 100.08 | Analyst | medium |
| PEG | 3Y | $249.51 | 26.2 | 9.54 | Analyst | medium |
| Peer P/B | 5Y | $414.24 | 1.9 | 214.47 | Hist. CAGR(prov.) | medium |
| Peer P/E | 5Y | $165.45 | 13.2 | 12.54 | Analyst | medium |
| Peer P/S | 5Y | $427.16 | 3.2 | 131.57 | Analyst | medium |
| PEG | 5Y | $328.03 | 26.2 | 12.54 | Analyst | medium |